Complex therapy diabetic microangiopathywith using of a preparation doxihem


Cite item

Full Text

Abstract

The aim of research was to compare efficacy of complex therapy diabetic microangiopathy to using doxihem with
standard therapy. 40 patients, 40-65 years, with diabetes mellitus type II with an arterial hypertension and presence of
microangiopathy were enrolled in the study. All patients received basic therapy with oral antidiabetes drugs in a combination
to an angiotensin converting enzyme (ACE) inhibitor. In experienced group to main therapy was added doxihem on
500 mg 3 times a day. For an evaluation of efficacy of therapy researched rheological parameters of a blood, changes on
an eye-ground, function of kidney, signs of peripheral neuropathy. The obtained data testify, that the using doxihem in
complex therapy diabetes mellitus type II such as at initial exhibitings microangiopathy allows to slow down development
of microvascular complications.

References

  1. Балаболкин М.И., Клебанова Е.М. // Cons. Med. - 2002. - Т. 2, № 5. - С. 18-22.
  2. Галстян Г.Р. // РМЖ-2002. - Т. 10, № 27. - С. 23-26.
  3. Rota R., Chiavaroli C., Garay R.P., et al. // EurJ. Pharmacol. - 2004. - Vol. 495(2-3). - Р. 217-24.
  4. Stitt A.W. // Brit. J. Ophthalmol. - 1998. - Vol. 79 - P. 362-367
  5. Williamson J.R., Tilton R.G., Chang K. // Diabetes Metabolism reviews. - 1998. - Vol. 4. - Р. 339-370.

Supplementary files

Supplementary Files
Action
1. JATS XML

Copyright (c) 2005 Sobolevskaya N.V., Spasov A.A., Petraevskiy A.V., Stepanov A.V., Statsenko M.E., Sobolevskaya N.V., Spasov A.A., Petraevsky A.V., Stepanov A.V., Statzenko M.E.

Creative Commons License
This work is licensed under a Creative Commons Attribution 4.0 International License.

СМИ зарегистрировано Федеральной службой по надзору в сфере связи, информационных технологий и массовых коммуникаций (Роскомнадзор).
Регистрационный номер и дата принятия решения о регистрации СМИ: серия ПИ № ФС 77 - 79562 от 27.11.2020 г.

This website uses cookies

You consent to our cookies if you continue to use our website.

About Cookies